<DOC>
	<DOCNO>NCT01483742</DOCNO>
	<brief_summary>This open-label , parallel cohort study evaluate safety , pharmacokinetics antiviral activity ritonavir-boosted danoprevir combination Pegasys ( peginterferon alfa-2a ) ribavirin treatment-naïve patient , RO5024048 add combination treatment prior null responder patient chronic hepatitis C genotype 1 4 compensated cirrhosis . All patient receive danoprevir 100 mg orally twice daily ( bid ) , ritonavir 100 mg orally bid , Pegasys 180 mcg subcutaneously weekly ribavirin 1000-1200 mg/kg/day orally . Prior non-responders receive RO5024048 1000 mg orally bid additionally . Anticipated time study treatment 24 week .</brief_summary>
	<brief_title>A Study Ritonavir-Boosted Danoprevir RO5024048 Different Combinations Null Responder Treatment-Naïve Patients With Chronic Hepatitis C Compensated Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<criteria>Adult patient , 18 65 year age inclusive Chronic hepatitis C , genotype 1 4 Cohort 1 : Treatmentnaïve hepatitis C Cohort 2 : Prior null responder treatment approve dos pegylated interferon plus ribavirin Liver biopsy confirm cirrhosis Compensated cirrhosis ( ChildPugh A ) Pregnant lactate woman male partner woman pregnant History presence decompensated liver disease ( ascites , hepatic encephalopathy , hepatocellular carcinoma , bleed esophageal varix ) Cohort 2 : Patients discontinue previous pegylated interferon plus ribavirin treatment due reason null response History clinically significant cardiovascular cerebrovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>